Page 22 - Bringing UHN into Focus - 2015-2016 Year in Review
P. 22

TApEr/A15MMaEyN/15GJAunG/1E5 MJuEl/N15T Aug/15 Sept/15 Oct/15 Nov/15 Dec/15 Jan/16 Feb/16 Mar/16

First lab in Canada to offer amyloid
subtypITiTnRAgNSFfOoRMrATpIONatients

                   UHN’s Laboratory Medicine Program                    “Management of amyloidosis relies on the treatment
                                                                        of the underlying cause of the disease differs radically
                isRtEhSe EfirAstRlCabHinACNaDnaIdNa NtoOoVffeArTION     for each different type of amyloid,” says Dr. Vathany
                                                                        Kulasingam, Biochemist, Laboratory Medicine
                   amyloidosis subtyping – a test to                    Program (LMP). “A clear diagnosis and subtype
                   identify the specific type of amyloid                characterization is essential.”
                   that has been deposited, so that                     But Dr. Rohan John, Pathologist, LMP, says when
treatment can be tailored to the patient.                               patients initially present with symptoms – such as
                                                                        arrhythmia or vomiting – there could be a multitude
Amyloidosis is aMgrIoCuHp EofNdEisReaIsNesTiEnGwRhiAcThIoOnNe           of reasons as to why.
                                                                        “We need to know whether or not the patient has
or more organ systems in the body accumulate                            amyloidosis because they are very sick and can’t wait
deposits of abnormal proteins called amyloids. The                      for an answer,” Dr. John says. “We recognized this as
patient’s symptoms may vary depending on where                          an opportunity to improve how we deliver care to our
in the body the amyloid deposits have accumulated,                      patients.
though amyloidosis frequently affects the vital organs:                 “So, a decision was made to bring the test in house in
heart, kidneys, liver, spleen, nervous system and                       order to provide faster, better care to our patients.”
gastrointestinal tract.
One form of amyloid can be a life-threatening                                              Link to full story: click here.
complication associated with some cancers, most
significantly multiple myeloma.
The symptoms associated with this disease are
progressive and severe.

                                                                        Also Making News

           Dr. Andrea Bozovic and a mass spectrometer used for amyloid  Creating a safe space for psychiatric
           testing (Photo: UHN)                                         emergencies
                                                                        Patient regains strength and stability
22                                                                      after brain tumour
                                                                        UHN student triumphs on CBC’s
                                                                        Dragons’ Den

                                                                                                              Bringing UHN into Focus
   17   18   19   20   21   22   23   24   25   26   27